108 related articles for article (PubMed ID: 17096546)
1. Amphiphilic poly(vinyl alcohol) derivatives as complexing agents for fenretinide.
Orienti I; Zuccari G; Bergamante V; Mileo E; Lucarini M; Carosio R; Montaldo PG
Biomacromolecules; 2006 Nov; 7(11):3157-63. PubMed ID: 17096546
[TBL] [Abstract][Full Text] [Related]
2. Fenretinide-polyvinylalcohol conjugates: new systems allowing fenretinide intravenous administration.
Orienti I; Zuccari G; Bergamante V; Carosio R; Gotti R; Cilli M; Montaldo PG
Biomacromolecules; 2007 Oct; 8(10):3258-62. PubMed ID: 17883277
[TBL] [Abstract][Full Text] [Related]
3. Improvement of aqueous solubility of fenretinide and other hydrophobic anti-tumor drugs by complexation with amphiphilic dextrins.
Orienti I; Zuccari G; Carosio R; Montaldo PG
Drug Deliv; 2009 Oct; 16(7):389-98. PubMed ID: 19624248
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of polyvinyl alcohol-co-oleylvinyl ether derivatives as tumor-specific cytotoxic systems.
Orienti I; Zuccari G; Carosio R; Montaldo PG
Biomacromolecules; 2005; 6(5):2875-80. PubMed ID: 16153130
[TBL] [Abstract][Full Text] [Related]
5. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles.
Zuccari G; Carosio R; Fini A; Montaldo PG; Orienti I
J Control Release; 2005 Mar; 103(2):369-80. PubMed ID: 15763620
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of oleyl alcohol anti tumor activity through complexation in polyvinylalcohol amphiphilic derivatives.
Orienti I; Zuccari G; Bergamante V; Fini A; Carosio R; Montaldo PG
Drug Deliv; 2007 Apr; 14(4):209-17. PubMed ID: 17497353
[TBL] [Abstract][Full Text] [Related]
7. Micellar complexes of all-trans retinoic acid with polyvinylalcohol-nicotinoyl esters as new parenteral formulations in neuroblastoma.
Zuccari G; Bergamante V; Carosio R; Gotti R; Montaldo PG; Orienti I
Drug Deliv; 2009 May; 16(4):189-95. PubMed ID: 19241235
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antitumor activity of the novel derivatized polyvinyl alcohol-based polymer P10(4).
Raffaghello L; Zuccari G; Carosio R; Orienti I; Montaldo PG
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3485-93. PubMed ID: 16740774
[TBL] [Abstract][Full Text] [Related]
9. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(d,l-lactide-co-glycolide): effects of polymer structure on cytotoxicity.
Unger F; Wittmar M; Kissel T
Biomaterials; 2007 Mar; 28(9):1610-9. PubMed ID: 17196250
[TBL] [Abstract][Full Text] [Related]
10. Biophysical and transfection studies of an amine-modified poly(vinyl alcohol) for gene delivery.
Wittmar M; Ellis JS; Morell F; Unger F; Schumacher JC; Roberts CJ; Tendler SJ; Davies MC; Kissel T
Bioconjug Chem; 2005; 16(6):1390-8. PubMed ID: 16287235
[TBL] [Abstract][Full Text] [Related]
11. Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications.
Chun C; Lee SM; Kim SY; Yang HK; Song SC
Biomaterials; 2009 Apr; 30(12):2349-60. PubMed ID: 19178941
[TBL] [Abstract][Full Text] [Related]
12. Enhanced in vivo antitumor efficacy of fenretinide encapsulated in polymeric micelles.
Okuda T; Kawakami S; Higuchi Y; Satoh T; Oka Y; Yokoyama M; Yamashita F; Hashida M
Int J Pharm; 2009 May; 373(1-2):100-6. PubMed ID: 19429294
[TBL] [Abstract][Full Text] [Related]
13. Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex.
Maurer BJ; Kalous O; Yesair DW; Wu X; Janeba J; Maldonado V; Khankaldyyan V; Frgala T; Sun BC; McKee RT; Burgess SW; Shaw WA; Reynolds CP
Clin Cancer Res; 2007 May; 13(10):3079-86. PubMed ID: 17505011
[TBL] [Abstract][Full Text] [Related]
14. Enhanced anti-neuroblastoma activity of a fenretinide complexed form after intravenous administration.
Carosio R; Pistoia V; Orienti I; Formelli F; Cavadini E; Mangraviti S; Montaldo PG; Ognio E; Emionite L; Zuccari G
J Pharm Pharmacol; 2012 Feb; 64(2):228-36. PubMed ID: 22221098
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids.
Cuperus R; Tytgat GA; Leen R; Brites P; Bras J; Caron HN; Van Kuilenburg AB
Int J Oncol; 2008 May; 32(5):1011-9. PubMed ID: 18425327
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide.
Formelli F; Cavadini E; Luksch R; Garaventa A; Villani MG; Appierto V; Persiani S
Cancer Chemother Pharmacol; 2008 Sep; 62(4):655-65. PubMed ID: 18066548
[TBL] [Abstract][Full Text] [Related]
17. Novel micelles based on amphiphilic branched PEG as carriers for fenretinide.
Orienti I; Zuccari G; Falconi M; Teti G; Illingworth NA; Veal GJ
Nanomedicine; 2012 Aug; 8(6):880-90. PubMed ID: 22094120
[TBL] [Abstract][Full Text] [Related]
18. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour.
Unger F; Wittmar M; Morell F; Kissel T
Biomaterials; 2008 May; 29(13):2007-14. PubMed ID: 18262641
[TBL] [Abstract][Full Text] [Related]
19. Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma.
Di Paolo D; Pastorino F; Zuccari G; Caffa I; Loi M; Marimpietri D; Brignole C; Perri P; Cilli M; Nico B; Ribatti D; Pistoia V; Ponzoni M; Pagnan G
J Control Release; 2013 Sep; 170(3):445-51. PubMed ID: 23792118
[TBL] [Abstract][Full Text] [Related]
20. Retention dynamics of amphiphilic polymers PEG-lipids and PVA-Alkyl on the cell surface.
Inui O; Teramura Y; Iwata H
ACS Appl Mater Interfaces; 2010 May; 2(5):1514-20. PubMed ID: 20450166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
